Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 1;6(1):278.
doi: 10.1186/s40792-020-01059-6.

Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report

Affiliations

Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report

Yoshihiro Miyagi et al. Surg Case Rep. .

Abstract

Background: Primary sclerosing cholangitis (PSC) is a well-known complication of ulcerative colitis (UC), but it is rare to encounter patients requiring both living donor liver transplantation (LDLT) and proctocolectomy. We report a case of elective two-stage surgery involving proctocolectomy performed after LDLT for a patient with early colon cancer concurrent with PSC-related UC. To our knowledge, this is the first report of concurrent cancer successfully treated with both LDLT and proctocolectomy.

Case presentation: A 32-year-old Japanese man with colon cancer associated with UC underwent restorative proctocolectomy at 3 months after living donor liver transplantation (LDLT) for PSC. He was diagnosed with PSC and UC when he was a teenager. Conservative therapy was initiated to treat both PSC and UC. He had experienced recurrent cholangitis for years; therefore, a biliary stent was placed endoscopically. However, his liver function progressively deteriorated. Colonoscopic surveillance revealed early colon cancer; hence, surgical treatment was considered. PSC progressed to cirrhosis and portal hypertension; hence, LDLT was performed before restorative proctocolectomy. Three months after LDLT, we performed restorative proctocolectomy with ileal pouch-anal anastomosis. The postoperative course was uneventful. The patient was well, with good liver and bowel functions and without tumor recurrence, more than 1 year after proctocolectomy.

Conclusions: With strict patient selection and careful patient management and follow-up, elective proctocolectomy may be performed safely and effectively after LDLT for concurrent early colon cancer with PSC-related UC. There are no previous reports of the use of both LDLT and proctocolectomy for the successful treatment of PSC-related UC and concurrent cancer.

Keywords: Colitis-related colon cancer; Ileal pouch–anal anastomosis; Inflammatory bowel disease; Small-for-size syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The imaging findings of primary sclerosing cholangitis (PSC) are shown. a Magnetic resonance cholangiopancreatography revealed typical features of PSC with irregular narrowing of bile ducts, stenoses, and focal dilatation of bile ducts. b Computed tomography revealed a cirrhotic liver with an enlarged caudate lobe and splenomegaly
Fig. 2
Fig. 2
Surveillance colonoscopy image showing an elevated lesion in the ascending colon (arrowheads). This lesion was diagnosed as well-differentiated adenocarcinoma based on the biopsy findings (arrow shows the biopsy area)
Fig. 3
Fig. 3
a Macroscopic findings of the resected lesion. Severe inflammation was observed in the whole colonic mucosa and the right colon was brown because of mucosal hemorrhages. b Slightly elevated lesion in the ascending colon. c Slightly elevated lesion in the transverse colon. d Histological examination of the tumor revealed well-differentiated to moderately differentiated adenocarcinoma in the mucosa of the ascending colon (hematoxylin and eosin staining; magnification, ×200)
Fig. 4
Fig. 4
Clinical course of the patient since PSC and UC were diagnosed

References

    1. Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013;382:1587–1599. doi: 10.1016/S0140-6736(13)60096-3. - DOI - PubMed
    1. Dyson JK, Beuers U, Jones DEJ, et al. Primary sclerosing cholangitis. Lancet. 2018;391:2547–2559. doi: 10.1016/S0140-6736(18)30300-3. - DOI - PubMed
    1. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan— analysis of 192 cases. J Gastroenterol. 1997;32:134–137. doi: 10.1007/BF01213311. - DOI - PubMed
    1. Kumagai J, Taida T, Ogasawara S, Nakagawa T, Iino Y, Shingyoji A, Ishikawa K, Akizue N, Yamato M, Takahashi K, Ohta Y, Hamanaka S, Okimoto K, Nakamura M, Ohyama H, Saito K, Kusakabe Y, Maruoka D, Yasui S, Matsumura T, Sugiyama H, Sakai Y, Mikata R, Arai M, Katsuno T, Tsuyuguchi T, Kato N. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients. PLoS ONE. 2018;13:e0209352. doi: 10.1371/journal.pone.0209352. - DOI - PMC - PubMed
    1. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994;343:71–74. doi: 10.1016/S0140-6736(94)90813-3. - DOI - PubMed

LinkOut - more resources